TR199901003T2 - Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im. - Google Patents

Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.

Info

Publication number
TR199901003T2
TR199901003T2 TR1999/01003T TR9901003T TR199901003T2 TR 199901003 T2 TR199901003 T2 TR 199901003T2 TR 1999/01003 T TR1999/01003 T TR 1999/01003T TR 9901003 T TR9901003 T TR 9901003T TR 199901003 T2 TR199901003 T2 TR 199901003T2
Authority
TR
Turkey
Prior art keywords
decongestant
asthma
treatment
composition containing
containing loratadine
Prior art date
Application number
TR1999/01003T
Other languages
English (en)
Turkish (tr)
Inventor
G. Harris Alan
Original Assignee
Schering Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corporation filed Critical Schering Corporation
Publication of TR199901003T2 publication Critical patent/TR199901003T2/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TR1999/01003T 1996-10-31 1997-10-29 Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im. TR199901003T2 (xx)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US73966996A 1996-10-31 1996-10-31

Publications (1)

Publication Number Publication Date
TR199901003T2 true TR199901003T2 (xx) 1999-07-21

Family

ID=24973307

Family Applications (1)

Application Number Title Priority Date Filing Date
TR1999/01003T TR199901003T2 (xx) 1996-10-31 1997-10-29 Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.

Country Status (21)

Country Link
EP (1) EP0941091A1 (no)
JP (1) JP2000505104A (no)
KR (1) KR20000052922A (no)
CN (1) CN1235545A (no)
AR (1) AR008908A1 (no)
AU (1) AU731756B2 (no)
BR (1) BR9712705A (no)
CA (1) CA2268546A1 (no)
CO (1) CO4910128A1 (no)
CZ (1) CZ150999A3 (no)
HU (1) HUP9904075A3 (no)
ID (1) ID23431A (no)
IL (1) IL129662A0 (no)
NO (1) NO992062D0 (no)
NZ (1) NZ335078A (no)
PE (1) PE11399A1 (no)
PL (1) PL333056A1 (no)
SK (1) SK54599A3 (no)
TR (1) TR199901003T2 (no)
WO (1) WO1998018470A1 (no)
ZA (1) ZA979731B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2307790A1 (en) * 1997-10-29 1999-05-06 J-Med Pharmaceuticals, Inc. Antihistamine/decongestant regimens for treating rhinitis
US6132758A (en) * 1998-06-01 2000-10-17 Schering Corporation Stabilized antihistamine syrup
IT1303671B1 (it) * 1998-07-28 2001-02-23 Nicox Sa Sali dell'acido nitrico con farmaci attivi nel trattamento dipatologie del sistema respiratorio
AR022378A1 (es) * 1998-09-10 2002-09-04 Schering Corp Metodos y composiciones para tratar sinusitis, otitis media y otros desordenes relacionados usando antihistaminas
US6521254B2 (en) 1998-12-07 2003-02-18 J-Med Pharmaceuticals, Inc. Single-dose antihistamine/decongestant formulations for treating rhinitis
ATE253354T1 (de) * 1999-02-23 2003-11-15 Yuhan Corp Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
KR100505899B1 (ko) * 1999-02-23 2005-08-01 주식회사유한양행 로라타딘과 슈도에페드린을 함유한 캅셀제 조성물
WO2000057880A1 (en) * 1999-03-29 2000-10-05 Schering Corporation Methods and compositions for treating allergic and related disorders using fluorinated descarboethoxyloratadine
AU2277101A (en) * 1999-12-20 2001-07-03 Schering Corporation Stable extended release oral dosage composition
SK287105B6 (sk) * 1999-12-20 2009-12-07 Schering Corporation Dvojvrstvový orálny dávkový prostriedok s predĺženým uvoľňovaním
JP5592042B2 (ja) * 2000-04-14 2014-09-17 ジェイ−メド ファーマシューティカルズ，インコーポレーティッド 鼻炎治療のための単一投与抗ヒスタミン薬／鬱血除去薬製剤
AU2001264806A1 (en) * 2000-05-25 2001-12-03 Schering Corporation Stable liquid and solid formulations
MXPA03011705A (es) * 2001-06-20 2004-03-19 Schering Corp Antihistaminas para el tratamiento de congestion nasal y obstruccion nasal.
AU2005333081B2 (en) * 2005-06-17 2010-06-24 Aft Pharmaceuticals Limited Novel pharmaceutical composition and its use in a method for treatment of patients with upper respiratory mucosal congestion
EP2366381A1 (en) * 2006-06-01 2011-09-21 MSD Consumer Care, Inc. Phenylephrine pharmaceutical formulations and compositions for colonic absorption
NZ573174A (en) * 2006-06-01 2012-01-12 Msd Consumer Care Inc Sustained release pharmaceutical dosage form containing phenylephrine
KR101540191B1 (ko) * 2014-02-24 2015-07-28 성균관대학교산학협력단 로라타딘을 포함하는 항염증용 조성물

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1110397A (en) * 1964-10-02 1968-04-18 Mead Johnson & Co Ephedrine composition
US4990535A (en) * 1989-05-03 1991-02-05 Schering Corporation Pharmaceutical composition comprising loratadine, ibuprofen and pseudoephedrine
US5407686A (en) * 1991-11-27 1995-04-18 Sidmak Laboratories, Inc. Sustained release composition for oral administration of active ingredient
US5314697A (en) * 1992-10-23 1994-05-24 Schering Corporation Stable extended release oral dosage composition comprising loratadine and pseudoephedrine
US5595997A (en) * 1994-12-30 1997-01-21 Sepracor Inc. Methods and compositions for treating allergic rhinitis and other disorders using descarboethoxyloratadine

Also Published As

Publication number Publication date
ZA979731B (en) 1998-04-29
HUP9904075A3 (en) 2002-02-28
EP0941091A1 (en) 1999-09-15
CO4910128A1 (es) 2000-04-24
CZ150999A3 (cs) 1999-10-13
KR20000052922A (ko) 2000-08-25
BR9712705A (pt) 1999-10-26
WO1998018470A1 (en) 1998-05-07
HUP9904075A2 (hu) 2000-05-28
JP2000505104A (ja) 2000-04-25
PE11399A1 (es) 1999-02-09
CA2268546A1 (en) 1998-05-07
AR008908A1 (es) 2000-02-23
NZ335078A (en) 2000-10-27
AU731756B2 (en) 2001-04-05
ID23431A (id) 2000-04-20
NO992062L (no) 1999-04-29
SK54599A3 (en) 2000-08-14
CN1235545A (zh) 1999-11-17
AU4995397A (en) 1998-05-22
PL333056A1 (en) 1999-11-08
IL129662A0 (en) 2000-02-29
NO992062D0 (no) 1999-04-29

Similar Documents

Publication Publication Date Title
TR199901003T2 (xx) Ast�m tedavisi i�in loratadin ve bir dekonjestan i�eren bile�im.
KR900009079A (ko) 비스(3,5-디-tert-부틸-4-히드록시페닐티오)메탄 함유 콜레스테롤 저하제겸 아테롬성 동맥 경화증 치료제
PT1157041E (pt) Anticorpos para terapia e diagnostico de cancro
DK0907365T3 (da) Hidtil ukendt formulering
ES2128552T3 (es) Combinacion de un inhibidor de la biosintesis del colesterol y un inhibidor de la absorcion del colesterol beta-lactama.
FI880464A0 (fi) Bekaempningsmedel mot tandplaque och -karies.
UA43378C2 (uk) Композиція для лікування респіраторного дистрес-синдрому новонароджених та респіраторного дистрес-синдрому дорослих
EE04576B1 (et) Suposiit happes ebapüsivate toimeainete tarbeks, selle valmistamismeetod, toimeaineühik ja selle valmistamismeetod ning preparaat
ATE353657T1 (de) Verwendung von immunerregenden oligonukleotiden zur vorbeugung oder behandlung von asthma
DE60128912D1 (en) Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika
GR3031250T3 (en) Methods of diagnosing and treating preeclampsia
SE9603725D0 (sv) New teatment
TR199900951T2 (xx) G���s kanserinin engellenmesi i�in y�ntemler.
DE69821498D1 (de) Verwendung von amifostin
GR3020355T3 (en) Aminosulfonyl urea acat inhibitors
DE69628743D1 (de) Levobupivacain und dessen verwendung als anästhetikum bei schwangeren frauen
TR199801988T2 (xx) Kalp yetmezli�inin endotelin antagonistleri ile tedavisi i�in y�ntem.
DE69924483D1 (de) Kombinationstherapie zur behandlung von tumoren
NO982582L (no) Fremgangsmaate for behandling av smerte
AU7439996A (en) Novel uses of mammalian ctla-8 and related reagents
NO985695L (no) Formulering og fremgangsmÕte for Õ behandle kongestiv hjerteinfarkt
LV11593A (lv) Dimetikona pielietojums aizcietejumu arstesana
TR200000728T2 (tr) Kronik hepatit C' nin tedavisinde IFN-alfa ve amantadin kullanımı.
DE69730045D1 (de) Behandlung der harninkontinenz und zusammenstellung dafür
NO984198D0 (no) Fremgangsmåte for behandling av aggresjon